InflaRx NV
NASDAQ:IFRX

Watchlist Manager

InflaRx NV

NASDAQ:IFRX

Watchlist

Dividends

Price: 1.82 USD 7.69% Market Closed

Market Cap: 122.2m USD

Have any thoughts about
InflaRx NV?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 1.82 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

IFRX Alert

InflaRx NV

1.82

+0.13 (+7.69%)

52 Week Range	0.9 2.7
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

InflaRx NV

What unique competitive advantages
does InflaRx NV hold over its rivals?

What risks and challenges
does InflaRx NV face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of InflaRx NV.

What unique competitive advantages
does InflaRx NV hold over its rivals?

What risks and challenges
does InflaRx NV face in the near future?

Summarize the latest earnings call
of InflaRx NV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for InflaRx NV.

Provide P/S
for InflaRx NV.

Provide P/E
for InflaRx NV.

Provide P/OCF
for InflaRx NV.

Provide P/FCFE
for InflaRx NV.

Provide P/B
for InflaRx NV.

Provide EV/S
for InflaRx NV.

Provide EV/GP
for InflaRx NV.

Provide EV/EBITDA
for InflaRx NV.

Provide EV/EBIT
for InflaRx NV.

Provide EV/OCF
for InflaRx NV.

Provide EV/FCFF
for InflaRx NV.

Provide EV/IC
for InflaRx NV.

Show me price targets
for InflaRx NV made by professional analysts.

What are the Revenue projections
for InflaRx NV?

How accurate were the past Revenue estimates
for InflaRx NV?

What are the Net Income projections
for InflaRx NV?

How accurate were the past Net Income estimates
for InflaRx NV?

What are the EPS projections
for InflaRx NV?

How accurate were the past EPS estimates
for InflaRx NV?

What are the EBIT projections
for InflaRx NV?

How accurate were the past EBIT estimates
for InflaRx NV?

Compare the revenue forecasts
for InflaRx NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of InflaRx NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of InflaRx NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of InflaRx NV compared to its peers.

Compare the P/E ratios
of InflaRx NV against its peers.

Discuss the investment returns and shareholder value creation
comparing InflaRx NV with its peers.

Analyze the financial leverage
of InflaRx NV compared to its main competitors.

Show all profitability ratios
for InflaRx NV.

Provide ROE
for InflaRx NV.

Provide ROA
for InflaRx NV.

Provide ROIC
for InflaRx NV.

Provide ROCE
for InflaRx NV.

Provide Gross Margin
for InflaRx NV.

Provide Operating Margin
for InflaRx NV.

Provide Net Margin
for InflaRx NV.

Provide FCF Margin
for InflaRx NV.

Show all solvency ratios
for InflaRx NV.

Provide D/E Ratio
for InflaRx NV.

Provide D/A Ratio
for InflaRx NV.

Provide Interest Coverage Ratio
for InflaRx NV.

Provide Altman Z-Score Ratio
for InflaRx NV.

Provide Quick Ratio
for InflaRx NV.

Provide Current Ratio
for InflaRx NV.

Provide Cash Ratio
for InflaRx NV.

What is the historical Revenue growth
over the last 5 years for InflaRx NV?

What is the historical Net Income growth
over the last 5 years for InflaRx NV?

What is the current Free Cash Flow
of InflaRx NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for InflaRx NV.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

IFRX Price Targets Summary
InflaRx NV

Wall Street analysts forecast IFRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IFRX is 9.52 USD with a low forecast of 5.05 USD and a high forecast of 13.65 USD.

IFRX Average Forecast

Wall Street Target

9.52 USD

423% Upside

IFRX Highest Forecast

Wall Street Target

13.65 USD

650% Upside

Lowest

Price Target

5.05 USD

177% Upside

Average

Price Target

9.52 USD

423% Upside

Highest

Price Target

13.65 USD

650% Upside

InflaRx NV Competitors:
Price Targets

600201

Jinyu Bio-Technology Co Ltd

16% Upside

PRQR

ProQR Therapeutics NV

519% Upside

ACLX

Arcellx Inc

81% Upside

GNFT

Genfit SA

152% Upside

600201

Jinyu Bio-Technology Co Ltd

16% Upside

PRQR

ProQR Therapeutics NV

519% Upside

ACLX

Arcellx Inc

81% Upside

GNFT

Genfit SA

152% Upside

688177

Bio-Thera Solutions Ltd

9% Upside

ELIC

Elicera Therapeutics AB

34% Downside

ALNY

Alnylam Pharmaceuticals Inc

14% Upside

NIOX

Niox Group PLC

24% Upside

Revenue
Forecast

Revenue Estimate
InflaRx NV

The compound annual growth rate of InflaRx NV's revenue for the next 3 years is 623%.

N/A

Past Growth

623%

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
InflaRx NV

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-2%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
InflaRx NV

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-51%

Average Miss

What are analyst estimates?

What is IFRX's stock price target?

Price Target
9.52 USD

According to Wall Street analysts, the average 1-year price target for IFRX is 9.52 USD with a low forecast of 5.05 USD and a high forecast of 13.65 USD.

What is InflaRx NV's Revenue forecast?

Projected CAGR
623%

The compound annual growth rate of InflaRx NV's revenue for the next 3 years is 623%.

	InflaRx NV NASDAQ:IFRX	1.82 USD 7.69%
C	Clarus Corp NASDAQ:CLAR	3.12 USD -1.58%
	Victory Capital Holdings Inc NASDAQ:VCTR	61.38 USD 0.02%

	Franklin Covey Co NYSE:FC	22.87 USD -1.55%
	Mohawk Industries Inc NYSE:MHK	101.1 USD -1.19%
	Ardmore Shipping Corp NYSE:ASC	9.77 USD 1.88%
	ASGN Inc NYSE:ASGN	53.55 USD -1.22%
	Skyworks Solutions Inc NASDAQ:SWKS	69.39 USD -1.38%
	Weatherford International PLC NASDAQ:WFRD	45.5 USD -1.37%

	Johnson & Johnson NYSE:JNJ	152.94 USD 0.22%
	Bank of America Corp NYSE:BAC	43.2 USD -0.25%
	Mastercard Inc NYSE:MA	563.58 USD -1.15%
	Salesforce Inc NYSE:CRM	273.13 USD -3.63%
	Abbvie Inc NYSE:ABBV	183.26 USD 0.39%
	Home Depot Inc NYSE:HD	362.71 USD -0.93%

	Arista Networks Inc NYSE:ANET	91.2 USD -1.47%
	Visa Inc NYSE:V	353.54 USD -1.24%
	Texas Pacific Land Corp NYSE:TPL	1 272.41 USD -0.51%
	KLA Corp NASDAQ:KLAC	757.17 USD -1.35%
	Manhattan Associates Inc NASDAQ:MANH	185.23 USD -1.21%
	Monolithic Power Systems Inc NASDAQ:MPWR	662.18 USD -1.49%

	ServiceNow Inc NYSE:NOW	1 004.37 USD -1.12%
	Spotify Technology SA NYSE:SPOT	653.82 USD 2.68%
	EOG Resources Inc NYSE:EOG	110.18 USD -0.55%
	Monster Beverage Corp NASDAQ:MNST	63.36 USD 0.78%
	Copart Inc NASDAQ:CPRT	53.67 USD -11.52%
	Applied Materials Inc NASDAQ:AMAT	157.51 USD -1.88%

InflaRx NV
NASDAQ:IFRX